ARKK stock forecast, quote, news & analysis

Key Takeaways

• ARKK gained roughly 13% over the trailing 30 days, rebounding from a late-July low near $71 to close near $83.
• The recovery was broad-based across the fund's disruptive-innovation holdings, led by its largest positions in electric vehicles, fintech, and AI-linked healthcare.
• Trailing three-month performance was far more muted — roughly flat to slightly higher — underscoring the ETF's high volatility.
• As an actively managed, concentrated portfolio of about 43 holdings with a 0.75% expense ratio, ARKK tends to amplify both gains and losses in high-growth, long-duration equities.
• Healthcare, technology, financial services, and consumer discretionary represent the fund's largest sector exposures.

ARK Innovation ETF (ARKK) Overview and Portfolio Exposure

The ARK Innovation ETF is an actively managed exchange-traded fund (ETF) sponsored by ARK Invest. The fund invests primarily in equity securities of companies tied to the theme of disruptive innovation, spanning areas such as genomics, autonomous technology, next-generation internet, fintech, and artificial intelligence (AI). Because it is actively managed rather than index-linked, its portfolio is deliberately concentrated and can shift materially as ARK's investment team adjusts positions.

The fund typically holds roughly 40 to 50 securities, with a weighted average market capitalization skewed toward large-cap and mega-cap names. Its expense ratio is 0.75%, and total assets under management (AUM) have recently been in the range of $6.5 billion to $7.3 billion. Sector exposure is anchored in healthcare (about 28%), information technology (roughly 26%), financial services (around 16%), consumer discretionary (approximately 14%), communication services (about 10%), and a smaller industrials sleeve.

Largest holdings have recently included Tesla (TSLA), Tempus AI (TEM), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Robinhood Markets (HOOD), SpaceX (privately held), Shopify (SHOP), Twist Bioscience (TWST), and Coinbase Global (COIN). This concentration — with the top position near 10% of assets — means a handful of high-beta names can drive a large share of the fund's price movement.

ARK Innovation ETF (ARKK) Price Performance: Last 30 Days vs. Quarter

Over the trailing 30 days, ARKK advanced approximately 13%, rising from a close near $73.54 to roughly $83.08. The move was not a straight line: the fund climbed steadily through much of August, consolidated, and then pulled back modestly from its late-August peak near $87.

The three-month picture is considerably more muted. Measured from early-June levels near $80, the fund closed only modestly higher — roughly 2% to 4% — despite a sharp mid-quarter drawdown. After sliding into the low-$70s in late July, ARKK staged a powerful recovery of more than 15% into late August before giving back a portion of those gains. This V-shaped pattern highlights the ETF's defining characteristic: high volatility driven by concentrated exposure to long-duration growth equities.

What Drove ARKK Price in the Last 30 Days

The 30-day advance largely reflected a broad recovery in high-growth, disruptive-innovation equities following the July pullback. Because ARKK is concentrated, its rebound was amplified by the performance of its largest, most interest-rate-sensitive holdings.

Electric-vehicle and autonomous-technology exposure, anchored by Tesla, is the fund's single largest position and carries outsized influence on daily price action. Fintech and crypto-adjacent names such as Coinbase, Robinhood, and Shopify — which tend to be highly sensitive to risk appetite — also contributed, as did AI-linked holdings including AMD and healthcare-technology positions like Tempus AI. The fund's heavy weighting to healthcare and technology meant a recovery in those sectors translated directly into ETF performance (a measure of how the fund's price responds to its underlying market).

The advance was consistent with improved investor sentiment toward growth-oriented sectors, although the fund's elevated volatility and concentrated structure meant the rebound was sharper than what a diversified, index-based portfolio would typically deliver.

What Drove ARKK Performance Over the Last Quarter

Across the trailing quarter, ARKK's net change was roughly flat to slightly positive, but that headline masks meaningful rotation beneath the surface. The fund declined into late July as high-valuation growth names came under pressure, then rebounded sharply as risk appetite recovered into August.

Several structural factors shaped the three-month trend. The fund's meaningful exposure to financial services — through fintech and digital-asset platforms — linked its performance to cryptocurrency sentiment and broader risk-on positioning. Its healthcare and genomics holdings, including CRISPR Therapeutics and Twist Bioscience, remained sensitive to clinical and regulatory news flow, while semiconductor and AI names tracked the broader technology cycle. Institutional ETF flows into disruptive-innovation strategies also ebbed and flowed with shifts in investor conviction around the long-duration growth trade, contributing to the period's wide trading range.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. The tool is designed to surface trending securities, breakout candidates, and emerging opportunities more efficiently than manual screening, allowing users to narrow a broad universe into a focused watchlist based on their own criteria. For investors tracking high-volatility, thematic vehicles like ARKK, the screener can help identify which underlying holdings and sectors are showing relative strength or weakness. Explore the AI Screener to streamline your research process.

ARKK ETF Outlook: What Investors Should Watch Next

Several factors are likely to influence ARKK over the coming months. Interest-rate expectations and inflation trends remain central, given the fund's bias toward long-duration, high-valuation growth companies that are typically more sensitive to discount-rate changes. The trajectory of the AI investment cycle — spanning semiconductors, software, and AI-enabled healthcare — will directly affect a meaningful portion of the portfolio.

Investors should also monitor the performance of the fund's largest holdings, particularly in electric vehicles and fintech, where competitive dynamics and regulatory developments can shift sentiment quickly. Digital-asset and crypto-adjacent exposure means cryptocurrency market conditions may continue to drive periodic swings. Finally, ETF capital flows into disruptive-innovation strategies and sector rotation between growth and value will likely shape near-term volatility. As always, the fund's concentrated structure means individual position moves can have an outsized effect on overall performance.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations